Inbentus Versatile
Iconic Solutions by Murcia, SL · Decision date Apr 14, 2026
What did the FDA decide?
FDA records K252663 as a 510(k) premarket notification, with a decision dated Apr 14, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Anesthesiology
- Decision date
- Apr 14, 2026
Regulatory record facts
- Identifier
- K252663
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Iconic Solutions by Murcia, SL
- Product code
- CBK
- Decision code
- SESE
- Decision date
- Apr 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventilator, Continuous, Facility Use.
- Applicant
- Iconic Solutions by Murcia, SL
- Product code
- CBK
- FDA device class
- 2
FDA decision timeline
K252663 received
Application receipt date recorded by FDA.
K252663 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code CBK
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Evita (V800); Evita (V600)K253647 | Draegerwerk AG & CO Kgaa | 510(k) clearance | May 7, 2026 | FDA |
VPAP Pediatric Face MaskK251888 | HSINER CO., LTD. | 510(k) clearance | Mar 12, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Iconic Solutions by Murcia, SL
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Murcia
Sources and methodology
- Original FDA record: K252663
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
